Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease (2013)

  • Authors:
  • USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
  • USP Schools: FM; FM
  • DOI: 10.1007%2Fs12017-012-8201-2
  • Subjects: DOENÇA DE ALZHEIMER; INFLAMAÇÃO; TRANSTORNOS COGNITIVOS; ADIPONECTINA (NÍVEL)
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007%2Fs12017-012-8201-2 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007%2Fs12017-012-8201-2 (Fonte: Unpaywall API)

    Título do periódico: NeuroMolecular Medicine

    ISSN: 1535-1084,1559-1174



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: NeuroMolecular Medicine

    ISSN: 1535-1084

    Citescore - 2017: 3.39

    SJR - 2017: 1.468

    SNIP - 2017: 0.906


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2338686-10BECEP 080 2013
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TEIXEIRA, Antonio L.; DINIZ, Breno S.; CAMPOS, Alline C.; et al. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, Totowa, v. 15, n. 1, p. 115-121, 2013. Disponível em: < http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2 > DOI: 10.1007%2Fs12017-012-8201-2.
    • APA

      Teixeira, A. L., Diniz, B. S., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2013). Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, 15( 1), 115-121. doi:10.1007%2Fs12017-012-8201-2
    • NLM

      Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2
    • Vancouver

      Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2

    Referências citadas na obra
    Arosio, B., Trabattoni, D., Galimberti, L., Bucciarelli, P., Fasano, F., Calabresi, C., et al. (2004). Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer’s disease. Neurobiology of Aging, 25(8), 1009–1015. doi: 10.1016/j.neurobiolaging.2003.10.009 .
    Bigalke, B., Schreitmuller, B., Sopova, K., Paul, A., Stransky, E., Gawaz, M., et al. (2011). Adipocytokines and CD34 progenitor cells in Alzheimer’s disease. PLoS ONE, 6(5), e20286. doi: 10.1371/journal.pone.0020286 .
    Calvani, M., Scarfone, A., Granato, L., Mora, E. V., Nanni, G., Castagneto, M., et al. (2004). Restoration of adiponectin pulsatility in severely obese subjects after weight loss. Diabetes, 53(4), 939–947.
    Diniz, B. S., Nunes, P. V., Yassuda, M. S., Pereira, F. S., Flaks, M. K., Viola, L. F., et al. (2008). Mild cognitive impairment: Cognitive screening or neuropsychological assessment? Revista Brasileira de Psiquiatria, 30(4), 316–321.
    Diniz, B. S., Teixeira, A. L., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2012). Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research, 46(8), 1081–1085. doi: 10.1016/j.jpsychires.2012.04.028 .
    Diniz, B. S., Teixeira, A. L., Ojopi, E. B., Talib, L. L., Mendonca, V. A., Gattaz, W. F., et al. (2010). Higher serum sTNFR1 level predicts conversion from mild Cognitive impairment to Alzheimer’s disease. Journal of Alzheimer’s Disease, 22(4), 1305–1311. doi: 10.3233/JAD-2010-100921 .
    Dzielinska, Z., Januszewicz, A., Wiecek, A., Demkow, M., Makowiecka-Ciesla, M., Prejbisz, A., et al. (2003). Decreased plasma concentration of a novel anti-inflammatory protein—adiponectin—in hypertensive men with coronary artery disease. Thrombosis Research, 110(5–6), 365–369.
    Fasshauer, M., Kralisch, S., Klier, M., Lossner, U., Bluher, M., Klein, J., et al. (2003). Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochemical and Biophysical Research Communications, 301(4), 1045–1050.
    Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198.
    Forlenza, O. V., Diniz, B. S., & Gattaz, W. F. (2010a). Diagnosis and biomarkers of predementia in Alzheimer’s disease. BMC Medicine, 8, 89. doi: 10.1186/1741-7015-8-89 .
    Forlenza, O. V., Diniz, B. S., Talib, L. L., Mendonca, V. A., Ojopi, E. B., Gattaz, W. F., et al. (2009). Increased serum IL-1beta level in Alzheimer’s disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders, 28(6), 507–512. doi: 10.1159/000255051 .
    Forlenza, O. V., Diniz, B. S., Talib, L. L., Radanovic, M., Yassuda, M. S., Ojopi, E. B., et al. (2010b). Clinical and biological predictors of Alzheimer’s disease in patients with amnestic mild cognitive impairment. Revista Brasileira de Psiquiatria, 32(3), 216–222.
    Giordano, V., Peluso, G., Iannuccelli, M., Benatti, P., Nicolai, R., & Calvani, M. (2007). Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer’s dementia. Neurochemistry Research, 32(4–5), 555–567. doi: 10.1007/s11064-006-9125-8 .
    Gu, Y., Luchsinger, J. A., Stern, Y., & Scarmeas, N. (2010). Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer’s disease. Journal of Alzheimer’s Disease, 22(2), 483–492. doi: 10.3233/JAD-2010-100897 .
    Hara, K., Horikoshi, M., Yamauchi, T., Yago, H., Miyazaki, O., Ebinuma, H., et al. (2006). Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 29(6), 1357–1362. doi: 10.2337/dc05-1801 .
    Hayes, A., Thaker, U., Iwatsubo, T., Pickering-Brown, S. M., & Mann, D. M. (2002). Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer’s disease. Neuroscience Letters, 331(3), 171–174.
    Hivert, M. F., Sullivan, L. M., Fox, C. S., Nathan, D. M., D’Agostino, R. B., Sr, Wilson, P. W., et al. (2008). Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 93(8), 3165–3172. doi: 10.1210/jc.2008-0425 .
    Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., et al. (2009). Systemic inflammation and disease progression in Alzheimer disease. Neurology, 73(10), 768–774. doi: 10.1212/WNL.0b013e3181b6bb95 .
    Kobayashi, H., Ouchi, N., Kihara, S., Walsh, K., Kumada, M., Abe, Y., et al. (2004). Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circulation Research, 94(4), e27–e31. doi: 10.1161/01.RES.0000119921.86460.37 .
    Livak, K. J. (1999). Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genetic Analysis, 14(5–6), 143–149.
    Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., et al. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Medicine, 8(7), 731–737. doi: 10.1038/nm724 .
    McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34(7), 939–944.
    Mrak, R. E. (2009). Neuropathology and the neuroinflammation idea. Journal of Alzheimer’s Disease, 18(3), 473–481. doi: 10.3233/JAD-2009-1158 .
    Ouchi, N., Kihara, S., Funahashi, T., Matsuzawa, Y., & Walsh, K. (2003). Obesity, adiponectin and vascular inflammatory disease. Current Opinion in Lipidology, 14(6), 561–566. doi: 10.1097/01.mol.0000103609.38789.96 .
    Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., et al. (2004). Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry, 279(13), 12152–12162. doi: 10.1074/jbc.M311113200 .
    Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., et al. (2001). Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985–1992.
    Poehlman, E. T., & Dvorak, R. V. (1998). Energy expenditure in Alzheimer’s disease. Journal of Nutrition Health and Aging, 2(2), 115–118.
    Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., et al. (2007). Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins. Nature Medicine, 13, 1359–1362. doi: 10.1038/nm1653 .
    Roberts, R. O., Geda, Y. E., Knopman, D. S., Boeve, B. F., Christianson, T. J., Pankratz, V. S., et al. (2009). Association of C-reactive protein with mild cognitive impairment. Alzheimers & Dementia, 5(5), 398–405. doi: 10.1016/j.jalz.2009.01.025 .
    Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., et al. (1986). CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698–709.
    Sonnen, J. A., Santa Cruz, K., Hemmy, L. S., Woltjer, R., Leverenz, J. B., Montine, K. S., et al. (2011). Ecology of the aging human brain. Archives of Neurology, 68(8), 1049–1056. doi: 10.1001/archneurol.2011.157 .
    Spranger, J., Verma, S., Gohring, I., Bobbert, T., Seifert, J., Sindler, A. L., et al. (2006). Adiponectin does not cross the blood-brain barrier but modifies cytokine expression of brain endothelial cells. Diabetes, 55(1), 141–147.
    Tarkowski, E., Andreasen, N., Tarkowski, A., & Blennow, K. (2003). Intrathecal inflammation precedes development of Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry, 74, 1200–1205.
    Taylor, V. H., & Macqueen, G. M. (2010). The role of adipokines in understanding the associations between obesity and depression. Journal of Obesity,. doi: 10.1155/2010/748048 .
    Une, K., Takei, Y. A., Tomita, N., Asamura, T., Ohrui, T., Furukawa, K., et al. (2011). Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease. European Journal of Neurology, 18(7), 1006–1009. doi: 10.1111/j.1468-1331.2010.03194.x .
    van Himbergen, T. M., Beiser, A. S., Ai, M., Seshadri, S., Otokozawa, S., Au, R., et al. (2012). Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and Alzheimer disease: Results from the Framingham Heart Study. Archives of Neurology, [Epub ahead of print]. doi: 10.1001/archneurol.2011.670 .
    Wolf, A. M., Wolf, D., Rumpold, H., Enrich, B., & Tilg, H. (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochemical and Biophysical Research Communications, 323(2), 630–635. doi: 10.1016/j.bbrc.2004.08.145 .
    Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., et al. (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96(5), 1723–1732.
    Zuliani, G., Ranzini, M., Guerra, G., Rossi, L., Munari, M. R., Zurlo, A., et al. (2007). Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia. Journal of Psychiatric Research, 41, 686–693. doi: 10.1016/j.jpsychires.2006.02.008 .